Plus, news about Enliven Therapeutics, Merck's Keytruda and Celldex:
FDA places hold on Rein study: The agency has “non-clinical requests” for Rein Therapeutics’ Phase 2 trial in idiopathic pulmonary fibrosis, per a Thursday ...
↧